FAS and acute myeloid leukemia: We screened one AML cell line from the FASTS subset, MOLM13, and a second one with no FAS phenotype, NOMO1, collecting samples at 14 and 21 days after transduction with a five-day puromycin selection (Supplementary Data 6 and 7).